Allergy Diagnostics Market Report
Published Date: 22 April 2026 | Report Code: allergy-diagnostics
Allergy Diagnostics Market Size, Share, Industry Trends and Forecast to 2033
This report provides a comprehensive analysis of the Allergy Diagnostics market, covering key insights, trends, technologies, and a detailed forecast from 2023 to 2033, exploring market dynamics and opportunities for growth.
Key Takeaways
- Global market valued at $8.50 Billion in 2023, projected to reach $17.38 Billion by 2033.
- Projected expansion at a 7.2% CAGR between 2023 and 2033.
- North America is the largest and fastest-growing region, reflecting strong regional demand and investment.
- Skin prick tests and serological assays remain prominent diagnostic approaches in clinical settings.
- Major participants include Thermo Fisher Scientific, Roche Diagnostics, Mylan N.V., Abbott Laboratories, and LG Chem.
Allergy Diagnostics Market Report — Executive Summary
The allergy diagnostics market is experiencing sustained expansion driven by higher allergy prevalence, technological advances in testing, and greater emphasis on preventive care. From a baseline of $8.50 Billion in 2023, the sector is forecast to grow at a 7.2% CAGR through 2023 to 2033, reaching $17.38 Billion by 2033. Product categories such as diagnostic kits, laboratory services, and point-of-care devices are central to market development, while test formats including skin prick, serological assays, and patch tests underpin clinical diagnostics. Geographic dispersion shows North America leading both in scale and pace of growth. Competitive activity centers on portfolio enhancement and distribution reach, with Thermo Fisher Scientific, Roche Diagnostics, Mylan N.V., Abbott Laboratories, and LG Chem noted as prominent players. The report structure combines market sizing, segment analysis by product, test type, allergen and end user, and regional outlook, concluding with strategic considerations for stakeholders evaluating investments, partnerships, and product development.
Key Growth Drivers
- Rising global incidence of allergic conditions increasing demand for diagnostic services and products.
- Technological innovation in assays and devices improving diagnostic accuracy and expanding test capabilities.
- Greater focus on preventive healthcare prompting earlier and more frequent allergy screening.
- Adoption of point-of-care and home-based testing approaches increasing accessibility and convenience for patients.
- Expanding healthcare expenditure and investment in diagnostics infrastructure supporting market uptake.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $8.50 Billion |
| CAGR (2023-2033) | 7.2% |
| 2033 Market Size | $17.38 Billion |
| Top Companies | Thermo Fisher Scientific, Roche Diagnostics, Mylan N.V., Abbott Laboratories, LG Chem |
| Last Modified Date | 22 April 2026 |
Allergy Diagnostics Market Overview
Customize Allergy Diagnostics Market Report market research report
- ✔ Get in-depth analysis of Allergy Diagnostics market size, growth, and forecasts.
- ✔ Understand Allergy Diagnostics's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Allergy Diagnostics
What is the Market Size & CAGR of Allergy Diagnostics Market Report market in 2023?
Allergy Diagnostics Industry Analysis
Allergy Diagnostics Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Allergy Diagnostics Market Report Market Analysis Report by Region
Europe Allergy Diagnostics Market Report:
Europe’s market expands from $2.67 Billion in 2023 to $5.46 Billion in 2033. Growth is underpinned by rising clinical awareness, investments in laboratory services, and adoption of established test formats such as skin prick and serological assays.Asia Pacific Allergy Diagnostics Market Report:
Asia Pacific grows from $1.62 Billion in 2023 to $3.32 Billion in 2033. Regional expansion is linked to increasing allergy prevalence, broader access to diagnostics, and gradual uptake of point-of-care devices and laboratory services.North America Allergy Diagnostics Market Report:
North America accounted for $2.9 Billion in 2023 and is projected to reach $5.93 Billion by 2033. The region’s leadership stems from advanced diagnostic infrastructure, strong healthcare spending, and rapid adoption of innovative testing platforms driving market momentum.South America Allergy Diagnostics Market Report:
Middle East & Africa Allergy Diagnostics Market Report:
Middle East and Africa’s market increases from $0.76 Billion in 2023 to $1.56 Billion in 2033, supported by investments in healthcare infrastructure, expanding laboratory capabilities, and rising recognition of allergy diagnostics.Tell us your focus area and get a customized research report.
Research Methodology
Allergy Diagnostics Market Analysis By Product Type
In 2023, the market for various product types in Allergy Diagnostics saw significant value distribution. Diagnostic kits dominated, valued at $5.72 billion in 2023, representing a 67.34% market share, and expected to reach $11.70 billion by 2033. Serological assays and laboratory services also held considerable shares, with values emerging at $1.93 billion (22.73%) and expected to scale up to $3.95 billion respectively by 2033.
Allergy Diagnostics Market Analysis By Allergen Type
The allergen type segment highlights significant contributors such as pollen, food allergens, and pet dander. Pollen, which constituted 57.05% of the market share in 2023 at $4.85 billion, will double to reach $9.91 billion in 2033. Food allergens and pet dander followed suit, progressing from $1.73 billion (20.37%) and $0.88 billion (10.33%) in 2023 to $3.54 billion and $1.79 billion respectively in 2033.
Allergy Diagnostics Market Analysis By Test Type
The differentiation of tests reveals a major dominance by skin prick tests and point-of-care devices, each generating substantial revenue by 2033. Skin prick tests grossed around $5.72 billion in 2023, with an excellent retention of market share at 67.34%, projected to sustain the same share till 2033.
Allergy Diagnostics Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Allergy Diagnostics Industry
Thermo Fisher Scientific:
A leading player in the field, known for its extensive range of allergy diagnostics and innovative testing technologies.Roche Diagnostics:
Renowned for its diagnostic solutions, particularly in serology and molecular assays aimed at allergy testing.Mylan N.V.:
A significant contributor in the development of allergy treatments and diagnostic kits, enhancing accessibility.Abbott Laboratories:
Offers a broad array of allergy diagnostics and has made strides in integrating technology with diagnostic processes.LG Chem:
Investing in research for new serological methods to improve testing accuracy in allergy diagnostics.We're grateful to work with incredible clients.
FAQs
What is the market size of the Allergy Diagnostics Market Report in 2023?
The Allergy Diagnostics market recorded a value of $8.50 Billion in 2023, serving as the baseline for projections through the 2023 to 2033 forecast period.
How big will the market be in 2033?
By 2033 the market is projected to reach $17.38 Billion, reflecting growth across the 2023 to 2033 forecast interval supported by technology and diagnostic uptake.
What is CAGR of the Allergy Diagnostics Market Report?
The market is estimated to grow at a 7.2% CAGR during the forecast period 2023 to 2033, driven by rising allergy prevalence and improvements in testing technologies.
Why is North America the largest region?
North America is both the largest and fastest-growing region, with market expansion from $2.9 Billion in 2023 to $5.93 Billion in 2033, supported by advanced diagnostics and healthcare investment.
Which companies lead the market?
Leading companies named include Thermo Fisher Scientific, Roche Diagnostics, Mylan N.V., Abbott Laboratories, and LG Chem, each contributing through product portfolios, diagnostics platforms, and regional distribution.
What are the primary test types in the market?
Skin prick tests, serological assays, and patch tests represent primary test types in the market, forming core diagnostic approaches for identifying allergens across clinical and laboratory settings.
How big is the Europe market?
Europe's market grows from $2.67 Billion in 2023 to $5.46 Billion in 2033, reflecting regional investments in diagnostics and increased awareness of allergic disorders across.
Who are common end users in the market?
Hospitals, diagnostic laboratories, and home care settings serve as principal end users, employing diagnostic kits, laboratory services, and point-of-care devices for allergy detection and management.
Why are point Of Care devices important?
Point-of-care devices expand access to allergy testing outside hospitals and labs, supporting quicker results, facilitating home-based diagnostics, and contributing to broader adoption of preventive care approaches.
What is the role of laboratory services?
Laboratory services provide confirmatory analyses through serological assays and complex testing, underpinning clinical diagnoses, enabling detailed allergen profiling, and supporting research and validation efforts consistently.